A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...

Recurrent aphthous stomatitis (RAS) is a common condition affecting 20-25% of the population, characterized by recurring oral ulcers. Aphthous ulcers are distinct from cold sores (herpes) and are not ...

Legendary MLS midfielder Darlington Nagbe will retire after the Columbus Crew's 2025 season, the player and club announced Tuesday. Nagbe has played the fifth-most regular-season games (444) in league ...

Today's Top Pick is a 1946 Taylorcraft BC-12D, a classic taildragger offering a pure and simple flying experience for those seeking aviation nostalgia. This vintage aircraft features a reliable 65 hp ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Secretary of the Navy John Phelan speaks to sailors aboard Nimitz-class aircraft carrier USS George Washington (CVN-73) on April 28, 2025. US Navy photo The Navy has 30 days to come up with a plan to ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

If the AquaNor conference in Trondheim feels busier this year, we might have land-based aquaculture to thank. Investment in the industry exceeded $1.3 billion during the first half of 2025 and could ...

WEST TURIN, N.Y. — Two people and three dogs were killed in a three-vehicle crash involving a tractor-trailer in Lewis County, New York State Police said. Authorities identified the deceased as ...

The new Heckert X90 has a Y travel path that can be extended from 51.2 in. (1,300 mm) to 55.2 in. (1,400 mm) and in Z from 55.2 in. (1,400 mm) to a maximum of 70.9 in. (1,800 mm). STARRAG is ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...